Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 16 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
Superinvestors holding ORKA, Q2 2026
1 superinvestor reports holding Oruka Therapeutics, Inc. on Form 13F, worth $143.1M in total. Weight is Oruka Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 0.4% | 1,503,478 | $143.1M | Reduced−43.6% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ORKA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−43.6%)
Q3 2025
1 superinvestor holding at quarter end